Safety of thrombolytic therapy for acute ischemic stroke after recent transient ischemic attack

Journal of Stroke and Cerebrovascular Diseases

Volumn 21, Issue 7, 2012, Pages 551-554

  McKinney, James S ^a   Masjuan, Jaime ^b   Purroy, Francisco ^c   Calvet, David ^d   Ay, Hakan ^e   Cucchiara, Brett L ^f  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

^c UNIVERSITY OF LLEIDA   (Spain)

^d CENTRE HOSPITALIER SAINTE ANNE   (France)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Hemorrhage; stroke; thrombolysis; tissue plasminogen activator; transient ischemic attack

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; CLOPIDOGREL; FIBRINOLYTIC AGENT; HEPARIN; WARFARIN;

ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG SAFETY; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; MALE; MECHANICAL THROMBECTOMY; PRIORITY JOURNAL; SCORING SYSTEM; SYMPTOMATIC INTRACEREBRAL HEMORRHAGE; THROMBOSIS; TRANSIENT ISCHEMIC ATTACK;

ADULT; AGED; AGED, 80 AND OVER; CEREBRAL HEMORRHAGE; EUROPE; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INFUSIONS, INTRA-ARTERIAL; INFUSIONS, INTRAVENOUS; ISCHEMIC ATTACK, TRANSIENT; MALE; MECHANICAL THROMBOLYSIS; MIDDLE AGED; RETROSPECTIVE STUDIES; STROKE; THROMBOLYTIC THERAPY; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 84866668702     PISSN: 10523057     EISSN: 15328511     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2010.12.008     Document Type: Article

References (19)

1. S.C. Johnston, D.R. Gress, and W.S. Browner Short-term prognosis after emergency department diagnosis of TIA JAMA 284 2000 2901 2906
2. S.C. Johnston, P.M. Rothwell, and M.N. Nguyen-Huynh Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack Lancet 369 2007 283 292
3. J.D. Easton, J.L. Saver, and G.W. Albers Definition and evaluation of transient ischemic attack: A scientific statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease. The American Academy of Neurology affirms the value of this statement as an educational tool for neurologists Stroke 40 2009 2276 2293
4. M.N. Nguyen-Huynh, and S.C. Johnston Is hospitalization after TIA cost-effective on the basis of treatment with tPA? Neurology 65 2005 1799 1801
5. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group N Engl J Med 333 1995 1581 1587
6. A. Furlan, R. Higashida, and L. Wechsler Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: A randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism JAMA 282 1999 2003 2011
7. W. Hacke, M. Kaste, and E. Bluhmki Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke N Engl J Med 359 2008 1317 1329
8. H.P. Adams Jr., G. del Zoppo, and M.J. Alberts Guidelines for the early management of adults with ischemic stroke: A guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists Circulation 115 2007 e478 534
9. J.N. Redgrave, S.B. Coutts, and U.G. Schulz Systematic review of associations between the presence of acute ischemic lesions on diffusion-weighted imaging and clinical predictors of early stroke risk after transient ischemic attack Stroke 38 2007 1482 1488
10. J. Masjuan, P. Simal, and B. Fuentes In-hospital stroke treated with intravenous tissue plasminogen activator Stroke 39 2008 2614 2616
11. F. Purroy, J. Montaner, and C.A. Molina Patterns and predictors of early risk of recurrence after transient ischemic attack with respect to etiologic subtypes Stroke 38 2007 3225 3229
12. D. Calvet, C. Lamy, and E. Touze Management and outcome of patients with transient ischemic attack admitted to a stroke unit Cerebrovasc Dis 24 2007 80 85
13. H. Ay, W.J. Koroshetz, and T. Benner Transient ischemic attack with infarction: A unique syndrome? Ann Neurol 57 2005 679 686
14. B.L. Cucchiara, S.R. Messe, and L. Sansing Lipoprotein-associated phospholipase A2 and C-reactive protein for risk-stratification of patients with TIA Stroke 40 2009 2332 2336
15. K.C. Johnston, D.P. Wagner, and X.Q. Wang Validation of an acute ischemic stroke model: Does diffusion-weighted imaging lesion volume offer a clinically significant improvement in prediction of outcome? Stroke 38 2007 1820 1825
16. W.S. Smith, G. Sung, and S. Starkman Safety and efficacy of mechanical embolectomy in acute ischemic stroke: Results of the MERCI trial Stroke 36 2005 1432 1438
17. The penumbra pivotal stroke trial: safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease Stroke 40 2009 2761 2768
18. M.F. Giles, and P.M. Rothwell Risk of stroke early after transient ischaemic attack: A systematic review and meta-analysis Lancet Neurol 6 2007 1063 1072
19. M. Selim, J.N. Fink, and S. Kumar Predictors of hemorrhagic transformation after intravenous recombinant tissue plasminogen activator: Prognostic value of the initial apparent diffusion coefficient and diffusion-weighted lesion volume Stroke 33 2002 2047 2052